TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

$80 Million

Bionano Genomics

Lead Placement Agent, October 2023

Bionano Genomics
Senior Secured Convertible Notes and Warrants

Bionano Genomics, Inc. (“Bionano” or the “Company”) (NASDAQ: BNGO) is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software. The Company offers OGM solutions for applications across basic, translational and clinical research.

More Like This

Mar 2024

Exchange of all Outstanding Series B Convertible Preferred Stock for Common Stock

Financial Advisor

View Details >
Mar 2024
$600 Million

Follow-on Offering

Bookrunner

View Details >
Mar 2024
$150 Million

Underwritten Offering

Lead Left Bookrunner

View Details >